Farmitalia

Farmitalia was an Italian pharmaceutical company best known for its parallel discovery with Rhone-Poulenc of daunorubicin and subsequent discovery of doxorubicin.[1] Farmitalia had been founded in 1935 as a joint venture by Rhone-Poulenc and Montecatini.[2] Farmitalia occupied a position of choice in the world rankings of the profession, not only in Italy, but also at the world level with in particular the patent of Adriamycin, an anti-cancer drug qualified. From its creation, Farmaceutici Italia buys the Schiapparelli factory.[3]

Farmitalia
IndustryPharmaceutical
Founded1935

In 1978, Farmitalia was merged with Carlo Erba SpA, an Italian pharmaceutical company that had been founded in 1853 by the pharmacist Carlo Erba, in which Montecatini had acquired a controlling interest in 1971. The merged company was called Farmitalia Carlo Erba SpA.[2]

Farmitalia Carlo Erba was acquired by Pharmacia in 1993,[4] then Pharmacia was acquired by Pfizer in 2003.[5]

Drugs discovered at Farmitalia that reached the market included (with date of first publication):

References
  1. Weiss RB (December 1992). "The anthracyclines: will we ever find a better doxorubicin?". Seminars in Oncology. 19 (6): 670–86. PMID 1462166.
  2. Bilotto, Antonella. "Carlo Erba SpA". LombardiaBeniCulturali. Retrieved 9 May 2017.
  3. http://admin (2019-04-17). "SETTIMO. La Farmitalia, storia di un'industria". Giornale La Voce (in Italian). Retrieved 2022-07-25.
  4. Staff. News: Farmitalia bought by Kabi Pharmacia. Ann Oncol (1993) 4 (5): 345.
  5. Staff, CNN/Money. April 16, 2003 It's official: Pfizer buys Pharmacia
  6. Baruffa, G (1966). "Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide". Trans R Soc Trop Med Hyg. 60 (2): 222–4. doi:10.1016/0035-9203(66)90030-7. PMID 5332105.
  7. Per prior citation, the first publication: Camerino, B; Palamidessi, G (1960). "Derivati della parazina II. Sulfonamdopir (in Italian)". Gazz Chim Ital. 90: 1802–1815.
  8. Suarato, A; Angelucci, F; Geroni, C (Mar 1999). "Ring-B modified anthracyclines". Curr Pharm Des. 5 (3): 217–27. doi:10.2174/1381612805666230109215627. PMID 10066891.
  9. Grein A, et al. Descrizione e classificazione di un attinomicete (Streptonryces peucetius sp. nova) produttore di una sostanza ad attivita antitumorale. Giorn. Microbiol. 11: 109~ 118, 1963
  10. Arcamone F, Cassinelli G, Fantini G, et al. (1969). "Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius". Biotechnol Bioeng. 11 (6): 1101–10. doi:10.1002/bit.260110607. PMID 5365804. S2CID 21897153.
  11. Council regulation (EEC) no 1768/92 in the matter of Application No SPC/GB94/012 for a Supplementary Protection Certificate in the name of Farmitalia Carlo Erba S. r. l.
  12. Espace record: GB 202074566
  13. Cocchiara, G; et al. (1991). "Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and man". Eur J Drug Metab Pharmacokinet. 16 (3): 231–9. doi:10.1007/bf03189965. PMID 1814741. S2CID 874781.
  14. First publication per prior citation: Melloni, M; et al. (1984). "Potential antidepressant agents. α-aryloxy-benzyl derivatives of ethanolamine and morpholine". Eur J Med Chem. 3: 235–242.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.